Laboratoires Pierre Fabre

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Laboratoires Pierre Fabre is a French multinational pharmaceutical and cosmetics company. The company had a consolidated turnover of 1.978 billion euros in 2012 (including 54% international).[1] It is headquartered in the city of Castres, Midi-Pyrénées, France.[1]

Founded in 1962 by Pierre Fabre (1926-2013),[1] the company is present in over 130 countries. Laboratories Pierre Fabre had approximately 10,000 employees in 2012, 33% of whom are internationally based, while the remaining 6,700 employees were based it France.[1] The company's business activity is focused on research, development, manufacturing and marketing of cosmetics, prescription medicines and family health products. Pharmaceuticals and phytotherapy represent 47% of turnover, whereas cosmetics represent 53% (percentages of 2012 turnover).

Pierre Fabre is best known for its vinorelbine (Navelbine), an anticancer drug of the vinca alkaloid class.

Olivier Bohuon, now Chief Executive of Smith & Nephew, was Chief Executive from September 2010 to April 2011.

The Pierre Fabre Foundation[edit]

The Pierre Fabre Foundation was recognized as a public utility in 1999 and its mission is to help third-world countries to obtain quality drug, ensure better quality control of drugs, use local therapeutic resources and train scientists for the inspection of drugs.

References[edit]

External links[edit]